|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300077360 |
|
最近更新日期: Date of Last Refreshed on: |
2023-11-06 16:59:24 |
|
注册时间: Date of Registration: |
2023-11-06 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
安徽心力衰竭多中心注册登记研究 |
|
Public title: |
Multi-center Heart Failure Registration Study in Anhui Province |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
安徽心力衰竭多中心注册登记研究 |
|
Scientific title: |
Multi-center Heart Failure Registration Study in Anhui Province |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈康玉 |
研究负责人: |
陈康玉 |
|
Applicant: |
Kangyu Chen |
Study leader: |
Kangyu Chen |
|
申请注册联系人电话: Applicant telephone: |
+86 180 5600 5099 |
研究负责人电话:
Study leader's |
+86 180 5600 5099 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
ahslyycky@126.com |
研究负责人电子邮件: Study leader's E-mail: |
ahslyycky@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
安徽省合肥市庐阳区庐江路17号 |
研究负责人通讯地址: |
安徽省合肥市庐阳区庐江路17号 |
|
Applicant address: |
17 Lujiang Road, Luyang District, Hefei, Anhui |
Study leader's address: |
17 Lujiang Road, Luyang District, Hefei, Anhui |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
安徽省立医院 |
||
|
Applicant's institution: |
Anhui Provincial Hospital |
||
|
研究负责人所在单位: |
安徽省立医院 |
||
|
Affiliation of the Leader: |
Anhui Provincial Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023KY伦审第310号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国科学技术大学附属第一医院医学研究伦理委员会 |
||
|
Name of the ethic committee: |
Medical Research Ethics Committee of the First Affiliated Hospital of University of Science and Technology of China |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-09-24 00:00:00 | ||
|
伦理委员会联系人: |
沈佐君 |
||
|
Contact Name of the ethic committee: |
Shen Zuojun |
||
|
伦理委员会联系地址: |
安徽省合肥市庐阳区庐江路17号 |
||
|
Contact Address of the ethic committee: |
17 Lujiang Road, Luyang District, Hefei, Anhui |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 551 6228 2931 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
安徽省立医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Anhui Provincial Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
安徽省合肥市庐阳区庐江路17号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
17 Lujiang Road, Luyang District, Hefei, Anhui |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self funded |
||||||||||||||||||||||
|
研究疾病: |
心力衰竭 |
||||||||||||||||||||||
|
Target disease: |
Heart Failure |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
本项目通过多中心观察性队列研究,记录心力衰竭患者基线、诊疗和随访数据,掌握安徽地区心力衰竭患者的流行病学特点,评估真实世界中的药物、手术等治疗方式的疗效和安全性,预测患者预后。 |
||||||||||||||||||||||
|
Objectives of Study: |
This project through multi-center obserational cohort study, record the baseline and follow-up data, diagnosis and treatment for heart failure patients, grasp the anhui regional epidemiological characteristics of patients with heart failure, to evaluate the treatment such as medicaments, operation in the real world of the efficacy and safety, and predict the prognosis of patients. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①年龄≥18岁; ②住院诊断为心力衰竭; ③签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1) Age ≥18 years old; 2) The patient was hospitalized with a diagnosis of heart failure; 3) All subjects gave informed consent to the content of the study and signed the informed consent form. |
||||||||||||||||||||||
|
排除标准: |
1) 妊娠或正准备妊娠及哺乳期妇女; 2)依从性差、认知障碍或其他原因不能配合完成研究的患者 |
||||||||||||||||||||||
|
Exclusion criteria: |
1) Pregnant or preparing to become pregnant and lactating women; 2) Patients with poor compliance, cognitive impairment or other reasons who cannot cooperate in completing the study; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-10-09 00:00:00至 To 2028-09-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-11-12 00:00:00 至 To 2028-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
未使用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not used |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
原始数据申请需提交研究计划书并经本试验管理委员会批准。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Applicants need provide a study proposal which will be approved by the trial steering committee |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
研究的数据将有第三方提供的电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The study data will be captured and managed by an Electronic Data Capture company. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |